Esoterix Inc
Project ID
104561
Facility Name
Esoterix Inc
Analyte
anti-Natalizumab antibodies (modification)
Method
electrochemiluminescence by Meso Scale Discovery platform
Specimen Type
plasma; serum
Permit Category
Ther. Sub. Mon./Quant. Tox.
Status
Conditionally Approved
Facility State
CA
Facility ID
3072